What if expectations AI will destroy jobs and be dominated by one expensive model are wrong? China might upend expectations, ...

The U.S. Economic Development Administration is awarding about $34 million in federal funding to the Kansas City BioSecure ...

Talawar Therapeutics ("Talawar" or the "Company"), a biotechnology company developing potentially best-in-class bispecific antibodies that pair independent immunology & inflammatory (I&I) disease ...

CFO hire bolsters Kalaris’ leadership team and supports continued growth of the company as it enrolls its Phase 1b/2 study of TH103 in treatment naïve nAMD patients BERKELEY HEIGHTS, N.J., July 20, ...

The HudsonAlpha Institute for Biotechnology has been awarded an initial $15 million, with the potential for up to $160 ...

BEIJING, Jul 18 (China Economic Net) – Pharmaceutical companies from Pakistan and China signed nine agreements and Memorandums of Understanding (MoUs) valued at over $440 million on Friday, covering ...

Two Kingston biotechnology companies are using support from Ontario Genomics‘ BioCreate — an accelerator program to advance ...

The approval of a new cell therapy for specific blood cancer transplant patients means more biotech jobs are coming to ...

Bambusa Therapeutics, Inc. (Bambusa Therapeutics or Bambusa), a clinical-stage biotechnology company advancing next-generation, long-acting bispecific antibodies for immunology and inflammation (I&I), ...

Slate Medicines (Slate), a privately-held biotech company advancing next-generation therapeutics for migraine and other headache disorders, today announced the appointment of Mark W. Hahn to the ...

The project's development and land disposition agreements will go before the Board of Alders' Community Development Committee during a public hearing at 6 p.m. Wednesday.

Coded cells are changing how modern day researchers develop drugs, for the benefit of the STEM space and society.